gmi 2018.png
Hemoglobin Testing Devices Market to hit $5 billion by 2025: Global Market Insights, Inc.
November 04, 2019 06:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Global Hemoglobin Testing Devices Market projected to cross is set to exceed USD 5 billion by 2025; according to a new research report by...
gmi 2018.png
Hemoglobin Testing Devices Market to hit $5 billion by 2025: Global Market Insights, Inc.
November 04, 2019 06:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Global Hemoglobin Testing Devices Market projected to cross is set to exceed USD 5 billion by 2025; according to a new research report by...
vynzresearch_logo.png
Global Immunoassay Market is Set to Reach USD 26.9 Billion by 2024, Growing at a CAGR of 5.6% During the Forecast Period: VynZ Research
July 09, 2019 03:11 ET | VynZ Research
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- The global Immunoassay market is predicted to grow at 5.6% CAGR during the forecast period with the market size reaching USD 26.9 billion by 2024. The...
gmi 2018.png
The Food Safety Testing Market to hit $24 billion by 2025: Global Market Insights, Inc.
March 06, 2019 20:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, March 06, 2019 (GLOBE NEWSWIRE) -- North America holds around 39% share in the global food safety testing market in 2018. High demand for rapid technology particularly for...
gmi 2018.png
HIV Diagnostics Market will surge at 8.7% CAGR to surpass $5 Bn by 2024: Global Market Insights, Inc.
December 12, 2018 01:35 ET | Global Market Insights, Inc
Sellbyville, Delaware, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Germany HIV diagnostics market held 20.9% revenue share of Europe in 2017 and is estimated to show lucrative growth over the forecast...
Akers Bio logo
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
October 08, 2018 02:00 ET | Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...